BG41129A3 - Method for preparing acetamide derivatives - Google Patents

Method for preparing acetamide derivatives

Info

Publication number
BG41129A3
BG41129A3 BG8569786A BG6978684A BG41129A3 BG 41129 A3 BG41129 A3 BG 41129A3 BG 8569786 A BG8569786 A BG 8569786A BG 6978684 A BG6978684 A BG 6978684A BG 41129 A3 BG41129 A3 BG 41129A3
Authority
BG
Bulgaria
Prior art keywords
acetamide derivatives
preparing acetamide
preparing
derivatives
oxothiazolidin
Prior art date
Application number
BG8569786A
Other languages
English (en)
Inventor
Satzinger
Herrmann
Fritschi
Hartenstein
Bartoszyk
Original Assignee
Goedecke Ag,Wb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag,Wb filed Critical Goedecke Ag,Wb
Publication of BG41129A3 publication Critical patent/BG41129A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
BG8569786A 1983-05-10 1984-05-08 Method for preparing acetamide derivatives BG41129A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3317000A DE3317000C2 (de) 1983-05-10 1983-05-10 4-Oxo-thiazolidin-2-yliden-acetamid-derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung von durch das Zentralnervensystem bedingten Konvulsionen

Publications (1)

Publication Number Publication Date
BG41129A3 true BG41129A3 (en) 1987-04-15

Family

ID=6198604

Family Applications (2)

Application Number Title Priority Date Filing Date
BG8465397A BG40143A3 (en) 1983-05-10 1984-05-08 Method for preparing acetamide derivatives
BG8569786A BG41129A3 (en) 1983-05-10 1984-05-08 Method for preparing acetamide derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG8465397A BG40143A3 (en) 1983-05-10 1984-05-08 Method for preparing acetamide derivatives

Country Status (19)

Country Link
US (1) US4563471A (ru)
EP (1) EP0124911B1 (ru)
JP (1) JPS59206372A (ru)
AT (1) ATE65778T1 (ru)
AU (1) AU565799B2 (ru)
BG (2) BG40143A3 (ru)
CA (1) CA1237436A (ru)
CS (1) CS244814B2 (ru)
DD (1) DD224319A5 (ru)
DE (2) DE3317000C2 (ru)
DK (1) DK162048C (ru)
ES (2) ES8502696A1 (ru)
GR (1) GR82086B (ru)
HU (1) HU190566B (ru)
IE (1) IE57372B1 (ru)
PL (2) PL142398B1 (ru)
SU (2) SU1251803A3 (ru)
YU (2) YU45183B (ru)
ZA (1) ZA843489B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269024A3 (en) * 1986-11-21 1990-05-09 Godecke Aktiengesellschaft Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
EP0715853A1 (en) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Use of glutathione esters for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
KR100329808B1 (ko) * 2000-01-14 2002-03-25 박호군 2-펜아실리덴-3,5-알킬치환된-1,3-티아졸리딘-4-온의 효율적 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1150985B (de) * 1961-03-06 1963-07-04 Warner Lambert Pharmaceutical Verfahren zur Herstellung von Thiazolidin-4-on-Derivaten
FR2726M (fr) * 1962-12-04 1964-08-17 Warner Lambert Pharmaceutical Amides de thiazolidinones substituées.
DE2423725C2 (de) * 1974-05-16 1982-12-30 Gödecke AG, 1000 Berlin 5-Phenyl-4-oxo-Delta 2,ALPHA-thiazolidinessigsäureester

Also Published As

Publication number Publication date
HU190566B (en) 1986-09-29
JPS59206372A (ja) 1984-11-22
DD224319A5 (de) 1985-07-03
SU1251803A3 (ru) 1986-08-15
CS244814B2 (en) 1986-08-14
JPS6316386B2 (ru) 1988-04-08
AU2788984A (en) 1984-11-15
ZA843489B (en) 1984-12-24
AU565799B2 (en) 1987-10-01
SU1272985A3 (ru) 1986-11-23
DK229984A (da) 1984-11-11
YU79284A (ru) 1986-10-31
PL247581A1 (en) 1985-07-16
DE3317000A1 (de) 1984-11-15
BG40143A3 (en) 1986-10-15
EP0124911B1 (de) 1991-07-31
ATE65778T1 (de) 1991-08-15
PL252100A1 (en) 1985-11-05
DK162048C (da) 1992-02-10
ES8502430A1 (es) 1985-01-01
IE57372B1 (en) 1992-08-12
DK162048B (da) 1991-09-09
DE3484859D1 (de) 1991-09-05
YU45183B (en) 1992-05-28
EP0124911A2 (de) 1984-11-14
ES532331A0 (es) 1985-01-16
DE3317000C2 (de) 1986-09-25
YU63586A (en) 1986-10-31
IE841150L (en) 1984-11-10
PL142398B1 (en) 1987-10-31
ES8502696A1 (es) 1985-01-16
GR82086B (ru) 1984-12-13
DK229984D0 (da) 1984-05-09
HUT34174A (en) 1985-02-28
PL142365B1 (en) 1987-10-31
EP0124911A3 (en) 1987-02-04
ES532322A0 (es) 1985-01-01
US4563471A (en) 1986-01-07
CA1237436A (en) 1988-05-31

Similar Documents

Publication Publication Date Title
DE3372769D1 (en) 3-aminoquinuclidin derivatives, process for their preparation and their use as therapeutical agents
EP0119954A3 (en) 3-amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use
HUT36116A (en) Process for producing n,n-piperazinyl- derivatives and pharmaceutical compositions containing them
ZA83743B (en) Pyrazolooxazines,pyrazolothiazines,and pyrazoloquinolines,process for their preparation and their use as medicaments
GR78442B (ru)
IL82231A (en) 1-hydroxy-2-pyridones,process for their preparation and pharmaceutical compositions which contain them
HUT39061A (en) Process for production of haploids, bihaploids and homozigota-plants from these substances
HUT46857A (en) Process for producing pharmaceutical compositions for treating bone-hurts
DE3375659D1 (en) Substituted phenylsulfonyloxybenzimidazole carbamates, process for their preparation and their application as medicaments
PT79220B (en) Process for preparing new pyridoindole derivatives useful as agents for the treatment of diseases of the centrel nervous system
BG40143A3 (en) Method for preparing acetamide derivatives
EP0267297A4 (en) SIALOSYLCHOLESTEROL, PROCESS FOR THE PREPARATION AND MEDICINE AGAINST DISORDERS OF THE NERVOUS SYSTEM.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
DE3367598D1 (en) 14-amino-steroid derivatives, their therapeutical use and process for their preparation
SG22688G (en) 3-3-dialkyl-and, 3,3-alkylene-indoline derivatives, processes for their production and pharmaceutical compositions comprising them
DE3368933D1 (en) Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
IL69546A (en) 3-hydroxymethyl-3-butenoic acid derivatives,processes for their preparation and process for the preparation of antibacterial 1-oxacepham derivatives using them
ZA832069B (en) 7-a-aminoacyl-3-chlorocephalosporins,process for their preparation and their use as medicaments
FR2540116B1 (fr) Nouvel antibiotique et antitumoral, la luzopeptine e2, son procede de preparation, et les compositions pharmaceutiques utilisant cet antibiotique
DE3066655D1 (en) Process for the production of n,n'-diaryl-alkylene diamines or n,n',n"-triaryl-dialkylene triamines
DE3465189D1 (en) Diversely substituted 1-arylamino-3-amino-2-propanols, process for their preparation and their therapeutical application
DE3461182D1 (en) 1-cycloalkylamino-3-tertiobutylamino-2-propanols, process for their preparation and their therapeutical application
HU911020D0 (en) Process for the production of medicative preparation for preventing and/or treating complaints occuring after menopausalis, postmenopausalis and ovariotomy
RO82461B1 (ro) Derivat al rifamicinei sv, utilizabil ca medicament citostatic si procedeu pentru prepararea acestuia
EP0087047A3 (en) Process for the preparation of n, and o, substituted urethanes